Xilio Therapeutics Inc.
(XLO)
undefined
undefined%
At close: undefined
1.00
1.94%
Pre-market Dec 16, 2024, 05:25 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 44.70M | 120.39M | 198.05M | 19.24M | 48.84M |
| Short-Term Investments | - | - | - | - | - |
| Long-Term Investments | - | 1.56M | 1.55M | 1.55M | 194.00K |
| Other Long-Term Assets | 1.60M | 267.00K | 1.95M | 500.00K | 1.55M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 3.42M | 8.22M | 8.93M | 1.35M | 2.26M |
| Total Current Assets | 48.13M | 124.50M | 202.52M | 20.59M | 51.10M |
| Property-Plant & Equipment | 11.20M | 12.84M | 13.60M | 13.68M | 9.87M |
| Goodwill & Intangibles | - | - | -5.09M | - | - |
| Total Long-Term Assets | 12.80M | 14.67M | 15.54M | 15.73M | 11.62M |
| Total Assets | 60.93M | 139.16M | 218.06M | 36.32M | 62.72M |
| Account Payables | 1.05M | 3.13M | 3.14M | 5.44M | 2.52M |
| Deferred Revenue | - | - | 8.75M | 13.73M | - |
| Short-Term Debt | 1.05M | 7.58M | 801.00K | 2.90M | - |
| Other Current Liabilities | 13.86M | 10.41M | 8.83M | 13.81M | 2.69M |
| Total Current Liabilities | 15.96M | 21.12M | 12.78M | 22.16M | 5.21M |
| Long-Term Debt | 16.28M | 12.35M | 19.73M | 18.32M | 18.63M |
| Other Long-Term Liabilities | -8.14M | 45.00K | 118.00K | 79.13M | 68.41M |
| Total Long-Term Liabilities | 8.14M | 12.40M | 19.85M | 97.45M | 87.04M |
| Total Liabilities | 24.10M | 33.52M | 32.63M | 119.60M | 92.25M |
| Total Debt | 11.46M | 19.94M | 20.54M | 21.22M | 18.63M |
| Common Stock | 3.00K | 3.00K | 3.00K | 1K | - |
| Retained Earnings | -325.51M | -249.11M | -160.89M | -85.09M | -29.87M |
| Comprehensive Income | - | - | -218.06M | -78.00M | - |
| Shareholders Equity | 36.83M | 105.65M | 185.43M | -83.29M | -29.52M |
| Total Investments | 1.59M | 1.56M | 1.55M | 1.55M | 194.00K |